Skip to content
Screener

Solid Biosciences Inc. SLDB External General And Administrative Expense — General And Administrative Expense

Other product segments

Internal General And Administrative Expense
$4.73M+40.9%

Similar metrics at other companies

Beam Therapeutics logo
BEAMExternal General And Administrative Expenses — General And Administrative Expense
$13.37M+149%
TRA
TRAXExternal Expenses — General And Administrative Expense
$8.72M+127%
AnaptysBio, Inc. logo
ANABExternal Expenses — General And Administrative Expense
$12.12M+119%
AnaptysBio, Inc. logo
ANABInternal Expenses — General And Administrative Expense
$14.08M+63.9%
TRA
TRAXInternal Expense — General And Administrative Expense
$10.14M+69.9%
Rein Therapeutics Inc. logo
RNTXEmployee Related Expenses — General And Administrative Expense
$859K-9.3%

Other financials

Income statement

See full
Revenue$2.0M-40.6%
Operating income-$57.4M-37.6%
Net income-$54.8M-38.8%
EPS (diluted)-$0.38+9.5%

Balance sheet

See full
Cash & equivalents$159.4M+14.7%
Total debt$20.2M-12.6%
Total equity$374.1M+44.8%
Total assets$420.6M+36.4%

Cash flow

See full
Operating cash flow-$52.6M-40.6%
CapEx$150.0K-60.2%
Free cash flow-$52.7M-39.6%

Valuation

See full
Market cap$857.5M+90.9%
Enterprise value$718.26M+114%

Profitability

See full
Operating margin-1,315.2%-4,060pp
Net margin-1,062.3%-251,151pp
FCF margin-1,247.7%-9,569pp

Returns & leverage

See full
Return on equity-65.5%-2.5pp
Debt / equity0.1×0.0×
Current ratio13.8×+4.5×

Where this comes from

Reported directly by Solid Biosciences Inc. in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The source filing: Solid Biosciences Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:04 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-337935
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
SGT-2122,3641,1455,6801,970
External R&D other1,9833,1164,8405,886
Internal R&D expense(1)9,0606,76518,21113,608
External G&A expense6,3275,27911,79510,156
Internal G&A expense(1)4,7343,3608,6006,823
Other segment items(2)7,4977,58615,79815,228
Other income, net(2,585)(2,213)(3,156)(2,983)
Condensed consolidated net loss$(54,799)$(39,480)$(111,536)$(78,762)

Item 1. Financial Statements (unaudited)

FAQ

What is Solid Biosciences Inc.'s external general and administrative expense — general and administrative expense?
Solid Biosciences Inc. (SLDB) reported external general and administrative expense — general and administrative expense of $6.33M in Q2 2026.
How has Solid Biosciences Inc.'s external general and administrative expense — general and administrative expense changed year-over-year?
Solid Biosciences Inc.'s external general and administrative expense — general and administrative expense increased by 19.9% year-over-year, from $5.28M to $6.33M.
What does external general and administrative expense — general and administrative expense mean?
This metric represents the portion of general and administrative expenses attributed to specific external business segments or product lines. It captures the overhead costs, such as management salaries, legal fees, and office expenses, that are directly allocated to support the operations of a particular segment. Monitoring this helps investors understand the cost structure and operational efficiency required to sustain specific business units.

Ask your AI about Solid Biosciences Inc.'s external general and administrative expense — general and administrative expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude